Acute Coronary Syndromes (ACS) in Pregnancy
Introduction
- đ Rare but critical: ACS in pregnancy is a rare cause of maternal mortality.
- đŠē Key to survival: Early recognition and a multidisciplinary team (MDT) approach improve outcomes.
Epidemiology and Risk Factors
Pathophysiology
- đ Physiological changes in pregnancy:
- 50% increase in blood volume and cardiac output.
- Increased basal heart rate; fluctuations in blood pressure and vascular resistance.
- Prothrombotic state increases risk throughout pregnancy and postpartum.
- đ Coronary Flow & Ischemia:
- Even minor reductions in coronary flow can cause ischemia due to increased cardiac demand.
Types of ACS
1️⃣ ST-Elevation Myocardial Infarction (STEMI):
- đ¨ Key Features:
- ST elevation/new LBBB on ECG + symptoms (chest pain, SOB, arrhythmias).
- Biomarkers raised, but ECG is diagnostic.
- đ Time-critical: Target: restore coronary flow within 1 hour.
- đŠē Accounts for ~75% of maternal ACS presentations.
2️⃣ Non-ST Elevation MI (NSTEMI):
- ⚠️ Clinical Presentation:
- May include ST depression/T-wave inversion or normal ECG.
- Raised biomarkers.
- đ ️ Requires individual risk assessment for emergency or conservative management.
3️⃣ Unstable Angina (UA):
- đĸ Symptoms: Chest pain or SOB at rest.
- ECG may resemble NSTEMI but no biomarker rise.
4️⃣ Stable Angina:
- ⏸️ Relieved by rest, no biomarker rise, and often normal ECG.
Aetiology of ACS in Pregnancy
-
𩸠PASCAD (Pregnancy-Associated SCAD):
- Found in ~27% of cases; up to 43% in older studies.
- Common in late third trimester/early postpartum.
- Intimal tear → false lumen → intramural hematoma → luminal collapse.
-
𩹠Atherosclerosis:
- Primary cause now due to maternal age and comorbidities.
- Plaque rupture → thrombosis → coronary flow obstruction.
- Seen in ~39–40% of cases.
-
đ Thrombosis/Thromboembolism:
- Found in 10–20% of cases.
-
đĸ Coronary Artery Spasm:
Clinical Presentation
-
đ Typical Symptoms:
- Chest or epigastric pain radiating to the neck or arm.
- Shortness of breath (SOB).
-
đ Atypical Symptoms (more common in women):
- Nonspecific pain, nausea, vomiting, and back pain.
- Dyspnoea, hyperhidrosis, and agitation.
-
⚠️ Critical Notes:
- Symptoms often downplayed or dismissed in pregnant women (cognitive diagnostic bias).
- Examination may be unremarkable.
- Vital signs may show haemodynamic instability.
-
đŠē ACS Subgroups Presentation:
- PASCAD, Thrombosis, Coronary Artery Spasm: Typically present as STEMI or NSTEMI.
- Atheromatous Disease: Can present as stable or unstable angina.
-
đ¨ Rare Presentation:
- Cardiac arrest – managed per maternal cardiac arrest guidelines.
- Always consider cardiac causes in cardiac arrest cases.
-
đ ️ Differential Diagnosis:
- Pulmonary embolism (PE).
- Aortic dissection.
- Pneumonia, gastro-oesophageal reflux disease, musculoskeletal pain, anxiety.
Investigations
Investigations for Myocardial Infarction (MI) đĨđ
-
Electrocardiography (ECG) đ
- đŠē First-line test for diagnosing MI in patients with chest pain.
- ⚡ ST elevation is the most specific marker.
- đ Serial ECGs are important as initial ECGs can be normal.
- đ Sensitivity of 12-lead ECG is ~50%, so other tests are needed.
-
Blood Cardiac Markers đЏ
- ✅ Troponin I & Troponin T – Best markers for MI.
- ⏳ Can take up to 12 hours to peak, so repeated testing is needed.
- đĢ Not affected by pregnancy, labor, or C-section.
- ⚠️ Raised in pre-eclampsia & hypertension but stays below MI levels.
-
Echocardiogram (Heart Ultrasound) đĻģđĢ
- đ Helps rule out other conditions like aortic dissection.
- đ Can assess heart function & wall motion abnormalities.
- 𤰠Safe to use in pregnancy.
-
Coronary Angiography đĨđĄ
- đ Gold standard for diagnosing & treating MI.
- đŠģ Uses X-ray and contrast dye to check for blocked arteries.
- 𤰠Safe in pregnancy if done with abdomen shielding & minimal radiation exposure.
Management of ACS in Pregnancy
General Principles
- đŠē Multidisciplinary Team (MDT):
- Involves obstetricians, cardiologists, anaesthetists, paediatricians, and the patient herself.
- Care should be provided in facilities equipped with cardiac and obstetric intensive care units.
- đ Goal:
- Stabilize the patient and individualize care based on clinical presentation and gestational age.
Reperfusion Therapy for STEMI in Pregnancy
-
Primary Percutaneous Coronary Intervention (PPCI) đđ
- Gold standard treatment for STEMI.
- Coronary angiography & stenting help restore blood flow.
- Bare metal stents (BMS) are preferred over drug-eluting stents due to limited safety data.
- Growing evidence supports successful PPCI outcomes in pregnancy.
-
Thrombolysis (Clot-Dissolving Therapy) đđЏ
- Used when PPCI is not immediately available.
- Intravenous t-PA (tissue plasminogen activator) is the preferred thrombolytic agent.
- Safe in pregnancy as it does not cross the placenta.
- Review of 28 case reports found no risk of birth defects (teratogenesis).
-
Risks & Considerations ⚠️
- Maternal bleeding risk (8%), which can lead to fetal distress.
- Decisions should be made in consultation with a cardiologist.
- Early intervention is crucial to improve outcomes for both mother and baby.
Management of Non-ST Elevation Myocardial Infarction (NSTEMI) in Pregnancy
𩸠First-Line Treatment: Antiplatelet Therapy
- Goal: Prevent further clot formation, dissolve existing clots, and improve blood flow to the heart.
- Medications Used:
- Aspirin (Low-Dose) – Safe in pregnancy; reduces clot formation.
- Clopidogrel (If Needed) – Used in selected cases but for the shortest duration possible.
đĨ Coronary Angiography & Stenting
- Indicated If:
- Symptoms persist despite medical treatment.
- Hemodynamic instability (low blood pressure, shock, etc.).
- High-risk patients even after symptoms improve.
- Procedure:
- Angiography assesses the blockage.
- Stenting (Revascularization) is done if required.
- Discussed in multidisciplinary team meetings to balance risks and benefits.
Medications Used in Acute Myocardial Infarction (AMI) in Pregnancy
for prevention and treatment 𩸠Antiplatelet & Anticoagulant Therapy
-
Aspirin (Low-Dose 60–150 mg) ✅
- First-line medication for preventing further clot formation.
- Safe in pregnancy (confirmed by the CLASP study).
- Slight increase in blood transfusion post-delivery, but no significant risks to the mother or baby.
- Avoid high-dose aspirin due to potential risks.
-
Clopidogrel (Thienopyridine Derivative) đ⚠️
- Used after stenting if needed.
- Limited safety data, so use for the shortest duration possible.
- A case study reported no adverse effects with 75 mg for 2 weeks after stenting in pregnancy.
-
Heparin (Low-Molecular-Weight & Unfractionated) ✅
- Safe in pregnancy as it does not cross the placenta.
- Used to prevent further clot formation.
- Must be stopped 24 hours before labor to avoid excessive bleeding.
đĢ Blood Pressure & Vasodilator Medications
-
Labetalol (Beta-Blocker) ✅
- Preferred beta-blocker for pregnancy.
- Safe for controlling blood pressure and reducing heart strain.
-
Nitrates (e.g., Nitroglycerin) ✅⚠️
- Used to widen blood vessels and improve blood flow.
- Can be used in severe hypertension, pulmonary edema, and AMI.
- Caution: Reports of fetal distress (bradycardia, loss of variability) with IV nitroglycerin.
-
Nifedipine (Calcium Channel Blocker) ⚠️
- Safe in pregnancy, but should be avoided after an acute coronary event due to increased mortality risk.
đĢ Medications Contraindicated in Pregnancy
-
ACE Inhibitors & ARBs (e.g., Enalapril, Losartan) ❌
- Severe fetal risks, including kidney damage, lung underdevelopment, growth restriction, and fetal death in the second & third trimester.
- First-trimester use can cause heart and brain defects.
-
Statins (e.g., Atorvastatin, Rosuvastatin) ❌
- Not recommended due to lack of safety data.
⏳ Timing of Delivery
- Delay delivery by 2–3 weeks post-AMI if possible to reduce maternal mortality risk.
- If preterm delivery is expected, administer maternal steroid injections early for fetal lung maturity.
- Delivery must take place in high-risk obstetric units with intensive care facilities.
𤰠Mode of Delivery: Vaginal vs. Cesarean Section
-
No clear preference—both vaginal and elective C-section are acceptable, depending on maternal & obstetric factors.
-
Vaginal Delivery Advantages
✔️ Less blood loss, infection, and thromboembolism risk
✔️ Epidural analgesia recommended to reduce stress on the heart & prevent excessive pushing.
✔️ Labour in the left lateral position to avoid pressure on major vessels.
✔️ Instrumental delivery (forceps/vacuum) advised to shorten the second stage and reduce heart strain.
-
Elective C-Section Advantages
✔️ Avoids labor-related hemodynamic stress (pain-induced BP spikes, pushing effort).
✔️ Allows planned delivery with a full medical team available.
⚠️ Key Considerations During Delivery
- Continuous Monitoring: Maternal ECG, pulse oximetry, BP, and fetal heart rate.
- Invasive Monitoring: Arterial catheter if left ventricular function is impaired.
- Oxytocin (Slow IV Infusion <2U/min) to reduce postpartum hemorrhage risk without causing hypotension.
- Avoid Ergometrine đĢ due to its vasoconstrictive effect, which can trigger coronary artery spasm.
đ Post-Delivery Care & Follow-Up
- High-dependency/ICU monitoring for 24–48 hours post-delivery due to fluid shifts & cardiovascular instability.
- Thromboembolic risk assessment & appropriate anticoagulation measures.
- AMI Management During Delivery:
- Beta-blockers, nitrates, and calcium channel blockers can be used if needed.
- Nitroglycerin & calcium channel blockers may prolong labor due to tocolytic effects.
- Postnatal Follow-Up:
- General practitioner & cardiologist must be updated.
- Contraception counseling based on cardiac function & AMI cause.
- Future pregnancy recommendations depend on maternal heart recovery.
5. Future Pregnancies
- đŠē Preconception Counseling:
- Essential for women with IHD or previous ACS.
- Optimize cardiac function and switch teratogenic drugs to safer alternatives.
- Delay pregnancy for at least 12 months post-acute coronary event.
- đĄ️ Contraception:
- Contraindicated methods: Estrogen-based contraceptives in IHD.
- Preferred: Progestin-only or non-hormonal methods.
Monitoring & Follow-Up
- đ Regular Monitoring:
- MDT involvement throughout pregnancy.
- Rapid assessment for any symptom changes.
- đ Risk Stratification:
- Use modified WHO classification for women with cardiac impairment (Class III/IV advised against pregnancy).
- đ Lifestyle Modifications:
- Address modifiable risk factors (obesity, smoking, hypertension).
Comments
Post a Comment